Physician profile
Edwin Eugene Henslee
NPI 1407991243
$7,883.89
in general payments reported to CMS, 2019-2025
26 companies · $5,756 in 2025
The $5,756 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $240 · 2021: $660 · 2022: $892 · 2023: $60.27 · 2024: $70.97 · 2025: $5,756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,500 · Travel and Lodging: $1,020 · Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,500.00 |
| Travel and Lodging | $1,019.70 |
| Food and Beverage | $367.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,339.30 | 2022-2025 | |
| Abbvie INC. | $465.96 | 2019-2023 | |
| Organon LLC | $157.96 | 2021-2025 | Nexplanon, Jada System |
| Merck Sharp & Dohme LLC | $109.87 | 2019-2020 | |
| Hologic Sales and Service, LLC | $104.05 | 2020-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Omni Hysteroscope |
| Mayne Pharma Commercial LLC | $85.82 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.42 | 2019-2021 | |
| Therapeuticsmd, INC. | $78.80 | 2020-2021 | |
| Ethicon US, LLC | $59.93 | 2021-2025 | Vistaseal |
| Davol INC. | $46.46 | 2021 | |
| Sumitomo Pharma America, INC. | $44.47 | 2025 | Myfembree |
| Lilly USA, LLC | $43.79 | 2020-2021 | |
| Pfizer INC. | $38.09 | 2024-2025 | |
| Eisai INC. | $32.53 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.05 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $20.36 | 2023 | |
| Glaxosmithkline, LLC. | $17.83 | 2020 | |
| Agile Therapeutics, INC. | $17.33 | 2021 | |
| Amgen INC. | $16.53 | 2019 | |
| Novo Nordisk INC | $14.79 | 2020 | |
| Coopersurgical, INC. | $14.21 | 2025 | Paragard T 380a |
| Avanos Medical | $13.82 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.58 | 2022 | |
| Mission Pharmacal Company | $13.29 | 2021 | |
| Medtronic, INC. | $12.37 | 2021 | |
| Evofem Biosciences, INC. | $12.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Henslee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.